For example, IRF1,14 IRF2,15 IRF3,16 IRF4,17 IRF718 and IRF819 intervene in PD‐1 blockade based immunotherapy and modulate the malignant progression of multiple tumours by regulating PD‐L1 expression. The gene discussed is CD274; the disease is neoplasm.